- Home
- CADL vs ACRE Comparison
CADL vs ACRE Comparison
Compare CADL & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- ACRE
- Stock Information
- Founded
- CADL 1999
- ACRE 2011
- Country
- CADL United States
- ACRE United States
- Employees
- CADL N/A
- ACRE N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- ACRE Real Estate Investment Trusts
- Sector
- CADL Health Care
- ACRE Real Estate
- Exchange
- CADL Nasdaq
- ACRE Nasdaq
- Market Cap
- CADL 234.8M
- ACRE 259.5M
- IPO Year
- CADL 2021
- ACRE 2012
- Fundamental
- Price
- CADL $4.81
- ACRE $4.83
- Analyst Decision
- CADL Strong Buy
- ACRE Hold
- Analyst Count
- CADL 4
- ACRE 7
- Target Price
- CADL $21.00
- ACRE $5.19
- AVG Volume (30 Days)
- CADL 843.6K
- ACRE 599.3K
- Earning Date
- CADL 05-20-2025
- ACRE 05-07-2025
- Dividend Yield
- CADL N/A
- ACRE 12.29%
- EPS Growth
- CADL N/A
- ACRE N/A
- EPS
- CADL N/A
- ACRE N/A
- Revenue
- CADL N/A
- ACRE $67,129,000.00
- Revenue This Year
- CADL N/A
- ACRE N/A
- Revenue Next Year
- CADL N/A
- ACRE $7.37
- P/E Ratio
- CADL N/A
- ACRE N/A
- Revenue Growth
- CADL N/A
- ACRE 83.51
- 52 Week Low
- CADL $3.79
- ACRE $3.35
- 52 Week High
- CADL $14.60
- ACRE $7.99
- Technical
- Relative Strength Index (RSI)
- CADL 42.39
- ACRE 70.34
- Support Level
- CADL $4.34
- ACRE $4.03
- Resistance Level
- CADL $5.34
- ACRE $4.00
- Average True Range (ATR)
- CADL 0.33
- ACRE 0.18
- MACD
- CADL 0.10
- ACRE 0.15
- Stochastic Oscillator
- CADL 47.11
- ACRE 95.24
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.